Mental health chain Jagruti raises $2.97M Series A from Alkemi
What's the deal? Pune-based Jagruti Rehabilitation Centre has raised US$3.8M in a Series A round led by Alkemi Growth CapitalDealroom has a profile for this one. Try Dealroom →. The provider of residential mental health, addiction, and dementia care will use the funds to enter new geographies, expand clinical and staffing capacity, add specialised care programmes, and deepen insurance and corporate partnerships.
Why now? This is Jagruti's first institutional round. Psychiatrist Amar Shinde and Vijaya Shinde founded the company in 2008 as a 10-bed centre, growing it to more than 19 centres across nine cities, with over 1,600 beds and 40 doctors — largely through internal accruals.
What's the endgame? Jagruti plans to more than double capacity to over 4,000 beds across 40-plus centres in Tier 1 and Tier 2 cities within three to four years. It claims to have treated more than 82,000 individuals to date.
Who's backing it? Alkemi Growth Capital, a Delhi-based fund focused on healthcare and consumer wellness, led the round. Its portfolio includes Redcliffe Labs, Datar Cancer Genetics, and emergency response provider MedulanceDealroom has a profile for this one. Try Dealroom →. Jagruti marks Alkemi's first bet on mental health and rehabilitation.
What could go wrong? India's rehabilitation sector remains fragmented, with care largely delivered through standalone clinics and small facilities. The key test is whether Jagruti can add beds and locations while holding clinical quality.
The signal: The round points to growing investor interest in organised, facility-based mental healthcare — a shift beyond digital apps and standalone clinics. Bengaluru's Amaha is reportedly raising US$13.6M to expand its hospital and clinic network, underlining the same momentum.
Read more: incubees.com
Image credit: mynameisharsha